Apple engineers reportedly are racing to create a software workaround ahead of a potential Apple Watch import ban in the United States over a patent claim. Apple reportedly hopes to make changes to the algorithm that measures a user’s blood oxygen saturation.
The move comes amid an ongoing patent dispute between Apple and Masimo, a medical devices company that says the Apple Watch’s blood oxygen feature breaches its patents. The International Trade Commission ruled earlier this year that Apple infringed on patents held by Masimo Corp., which could result in a ban on the import and sales of certain Apple Watches next week.
As a preemptive measure, Apple says it will pause Apple Watch Series 9 and Ultra 2 sales starting December 21. The company also began sending new marketing materials to its retail stores, promoting the Apple Watch without mentioning the Series 9 or Ultra 2. Apple’s decision to pause smartwatch sales does not affect the Apple Watch SE model, as it lacks a blood oxygen sensor.